Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

TORRENT PHARMA vs ADCOCK INGRAM (S. Africa) - Comparison Results

ADCOCK INGRAM (S. Africa)
   Change

Adcock Ingram is a leading South African pharmaceutical manufacturer, marketer and distributor. The company occupies 10% share of the private pharmaceutical market in South Africa with a strong presence in over-the-counter (OTC) brands. Adcock is als... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 TORRENT PHARMA   ADCOCK INGRAM
EQUITY SHARE DATA
    TORRENT PHARMA
Mar-23
ADCOCK INGRAM
Jun-14
TORRENT PHARMA/
ADCOCK INGRAM
5-Yr Chart
Click to enlarge
High Rs1,723320-   
Low Rs1,243231-   
Sales per share (Unadj.) Rs284.295.1-  
Earnings per share (Unadj.) Rs36.8-24.0-  
Cash flow per share (Unadj.) Rs57.7-19.9-  
Dividends per share (Unadj.) Rs22.000-  
Avg Dividend yield %1.50-  
Book value per share (Unadj.) Rs183.174.6-  
Shares outstanding (eoy) m338.45168.78-   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x5.22.9 180.3%   
Avg P/E ratio x40.3-11.5 -350.9%  
P/CF ratio (eoy) x25.7-13.9 -185.5%  
Price / Book Value ratio x8.13.7 219.6%  
Dividend payout %59.80-   
Avg Mkt Cap Rs m501,77946,446 1,080.4%   
No. of employees `000NA4.3 0.0%   
Total wages/salary Rs m16,7772,915 575.5%   
Avg. sales/employee Rs Th03,739.2-  
Avg. wages/employee Rs Th0679.0-  
Avg. net profit/employee Rs Th0-942.2-  
INCOME DATA
Net Sales Rs m96,20216,052 599.3%  
Other income Rs m632112 562.4%   
Total revenues Rs m96,83416,165 599.0%   
Gross profit Rs m28,240-2,782 -1,015.2%  
Depreciation Rs m7,066693 1,019.9%   
Interest Rs m3,334435 766.8%   
Profit before tax Rs m18,472-3,797 -486.5%   
Minority Interest Rs m0-11 -0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m6,019237 2,537.0%   
Profit after tax Rs m12,452-4,045 -307.9%  
Gross profit margin %29.4-17.3 -169.4%  
Effective tax rate %32.6-6.2 -521.5%   
Net profit margin %12.9-25.2 -51.4%  
BALANCE SHEET DATA
Current assets Rs m53,13711,757 452.0%   
Current liabilities Rs m54,4736,615 823.5%   
Net working cap to sales %-1.432.0 -4.3%  
Current ratio x1.01.8 54.9%  
Inventory Days Days15111 14.0%  
Debtors Days Days7124 6.0%  
Net fixed assets Rs m91,3906,853 1,333.5%   
Share capital Rs m1,69275 2,270.7%   
"Free" reserves Rs m60,2880-   
Net worth Rs m61,98112,599 491.9%   
Long term debt Rs m24,9624,428 563.8%   
Total assets Rs m144,68223,801 607.9%  
Interest coverage x6.5-7.7 -84.6%   
Debt to equity ratio x0.40.4 114.6%  
Sales to assets ratio x0.70.7 98.6%   
Return on assets %10.9-15.2 -71.9%  
Return on equity %20.1-32.1 -62.6%  
Return on capital %25.1-19.8 -126.6%  
Exports to sales %21.80-   
Imports to sales %00-   
Net fx Rs m17,2590-   
CASH FLOW
From Operations Rs m23,6811,370 1,728.3%  
From Investments Rs m-24,153-421 5,741.0%  
From Financial Activity Rs m7744,018 19.3%  
Net Cashflow Rs m1,1014,968 22.2%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ADCOCK INGRAM (S. Africa) is South Africa Rand. All data has been converted at 4.41 Rs / ZAR

Compare TORRENT PHARMA With: MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  

Compare TORRENT PHARMA With: HESTER BIOSCIENCES  CIAN HEALTHCARE  AJANTA PHARMA  ERIS LIFESCIENCES  LACTOSE INDIA  



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.